Press Releases

Reviva Pharmaceuticals to Present at the Lytham Partners Fall 2022 Investor Conference

Sep 26, 2022

Reviva Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Sep 07, 2022

Reviva Pharmaceuticals Holdings, Inc. Announces $8.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Sep 06, 2022

Reviva Pharmaceuticals Holdings, Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights

Aug 15, 2022

Reviva Pharmaceuticals Provides Update on Clinical Development Pipeline

Jul 27, 2022

Reviva Pharmaceuticals to Present at Upcoming June Investor Conferences

Jun 17, 2022

Reviva Pharmaceuticals to Participate in the 2022 BIO International Convention

Jun 02, 2022

Reviva Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

May 17, 2022

Reviva Pharmaceuticals Holdings, Inc. Reports First Quarter 2022 Financial Results and Recent Business Highlights

May 16, 2022

Reviva Pharmaceuticals Announces Update on RECOVER, a Pivotal Phase 3 Global Study Evaluating Brilaroxazine for the Treatment of Schizophrenia

May 03, 2022